@article{Saad_Canil_Finelli_Hotte_Malone_Shayegan_So_Aaron_Basappa_Conter_Danielson_Gotto_Hamilton_Izard_Kapoor_Kolinsky_Lalani_Lattouf_Morash_Morgan_Niazi_Noonan_Ong_Rendon_Sehdev_Hew_Park-Wyllie_Chi`_2019, title={Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum}, volume={14}, url={https://cuaj.ca/index.php/journal/article/view/6082}, DOI={10.5489/cuaj.6082}, abstractNote={<p><strong>Introduction:</strong> The management of advanced prostate cancer (PCa) continues to evolve with the emergence of new diagnostic and therapeutic strategies. As a result, there are multiple areas in this landscape with a lack of high-level evidence to guide practice. Consensus initiatives are an approach to establishing practice guidance in areas where evidence is unclear. We conducted a Canadian-based consensus forum to address key controversial areas in the management of advanced PCa.</p> <p><strong>Methods:</strong> As part of a modified Delphi process, a core scientific group of PCa physicians (n=8) identified controversial areas for discussion and developed an initial set of questions, which were then reviewed and finalized with a larger group of 29 multidisciplinary PCa specialists. The main areas of focus were non-metastatic castration-resistant prostate cancer (nmCRPC), metastatic castration-sensitive prostate cancer (mCSPC), metastatic castration-resistant prostate cancer (mCRPC), oligometastatic prostate cancer, genetic testing in prostate cancer, and imaging in advanced prostate cancer. The predetermined threshold for consensus was set at 74% (agreement from 20 of 27 participating physicians).</p> <p><strong>Results:</strong> Consensus participants included uro-oncologists (n=13), medical oncologists (n=10), and radiation oncologists (n=4). Of the 64 questions, consensus was reached in 30 questions (n=5 unanimously). Consensus was more common for questions related to biochemical recurrence, sequencing of therapies, and mCRPC.</p> <p><strong>Conclusions:</strong> A Canadian consensus forum in PCa identified areas of agreement in nearly 50% of questions discussed. Areas of variability may represent opportunities for further research, education, and sharing of best practices. These findings reinforce the value of multidisciplinary consensus initiatives to optimize patient care.</p>}, number={4}, journal={Canadian Urological Association Journal}, author={Saad, Fred and Canil, Christina and Finelli, Antonio and Hotte, Sebastien J. and Malone, Shawn and Shayegan, Bobby and So, Alan I. and Aaron, Lorne and Basappa, Naveen S. and Conter, Henry J. and Danielson, Brita and Gotto, Geoffrey and Hamilton, Robert J. and Izard, Jason P. and Kapoor, Anil and Kolinsky, Michael and Lalani, Aly-Khan A. and Lattouf, Jean-Baptiste and Morash, Christopher and Morgan, Scott C. and Niazi, Tamim and Noonan, Krista L. and Ong, Michael and Rendon, Ricardo A. and Sehdev, Sandeep and Hew, Huong and Park-Wyllie, Laura and Chi`, Kim N.}, year={2019}, month={Nov.}, pages={E137–49} }